Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy

European Journal of Nuclear Medicine

Volumn 25, Issue 12, 1998, Pages 1649-1657

  Soler, C ^a,b   Beauchesne, P ^a   Maatougui, K ^a   Schmitt, T ^a   Barral, F G ^a   Michel, D ^a   Dubois, F ^a   Brunon, J ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b SERVICE DE NEUROLOGIE   (France)

Author keywords

Brain single photon emission tomography; Gliomas; Radionecrosis; Technetium 99m sestamibi; Tumour recurrence

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COLLIMATOR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG TUMOR LEVEL; DRUG UPTAKE; FEMALE; GLIOMA; HUMAN; HYPOPHYSIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; RADIATION NECROSIS; RETROSPECTIVE STUDY; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR RECURRENCE;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; SURVIVAL RATE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

DETERIORATION; DISEASES; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; PARTICLE BEAMS; PHOTONS; POPULATION STATISTICS; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

BRAIN SINGLE-PHOTON EMISSION TOMOGRAPHY; GLIOMA; RADIONECROSIS; RECURRENT GLIOMAS; SINGLE PHOTON EMISSION TOMOGRAPHIES; SINGLE-PHOTON EMISSION TOMOGRAPHY; TC MIBI; TECHNETIUM-99M; TECHNETIUM-99M SESTAMIBI; TUMOR RECURRENCES;

TUMORS;

EID: 0032415995     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050344     Document Type: Article

References (36)

1. Black P. Brain tumors (first part). N Engl J Med 1991; 21:1471-1476. Brain tumors (second part). N Engl J Med 1991; 22: 1555-1564.
2. Black P. Brain tumors (first part). N Engl J Med 1991; 21:1471-1476. Brain tumors (second part). N Engl J Med 1991; 22: 1555-1564.
3. Mousseau M, Chauvin C, Nissou MF, et al. A study of the expression of 4 chemoresistance-related genes in human primary and metastatic brain tumors. Eur J Cancer 1993; 5: 7553-7559.
4. Fine HA, Dear KBG, Loeffler JS, et al. Meta-analysis of radiotherapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993; 71:2585-2597.
5. Carvalho P, Richard B, Schwartz B, et al. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 1992; 77: 565-570.
6. Vertosick F, Selker R, Grossman S, et al. Correlation of thallium-201 single-photon emission computerized tomography and survival after treatment failure in patients with glioblastoma multiforme. J Neurosurg 1992; 77: 565-570.
7. 18F) fluoro-2-desoxy-D-glucose in the low grade glioma. Neurosurgery 1996; 39: 470-477.
8. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma: a predictor of prognosis. Cancer 1988; 62: 1074-1078.
9. Kim EE, Chung SK, Haynie TP, et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 1992; 12: 269-279.
10. Patronas NJ, Di Chiro G, Kufta C, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985; 62: 816-822.
11. Dierckx RA, Martin JJ, Dobbeleir A, et al. Sensitivity and specificity of thallium-201 single-photon emission computerized tomography in the functional detection and differential diagnosis of brain tumors. Eur J Nucl Med 1994; 21: 621-623.
12. Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990; 31: 965-969.
13. Loberboym M, Baram J, Feibel M, et al. A prospective evaluation of thallium-201 single-photon emission computerized tomography for brain tumor burden. Int J Radiat Oncol Biol Phys 1995; 32: 249-254.
14. Namba H, Togawa T, Yui N, et al. The effect of steroid on thallium-201 uptake by malignant gliomas. Eur J Nucl Med 1996; 23: 991-992.
15. Ricci M, Pantano P, Pierallini A, et al. Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging. Eur J Nucl Med 1996; 23: 524-529.
16. Yoshii Y, Satou M, Yamamoto T, et al. The role of thallium-201 single-photon emission computerized tomography in the investigation and characterisation of brain tumors in man and their response to treatment. Eur J Nucl Med 1993; 20: 39-45.
17. Moody EM, Hodes JE. Thallium-avid cerebral radiation necrosis. Clin Nucl Med 1994; 19: 611-613.
18. 99mTc-sestamibi. Nucl Med Commun 1995; 16: 258-264.
19. Baillet G, Albuquerque L, Chen Q, et al. Evaluation of single-photon emission computerized tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 1994; 21: 1061-1066.
20. 99mTc-MIBI and 201 thallium by a 9L gliosarcoma brain tumor model in rats. Nucl Med Commun 1993; 20: 773-776.
21. Park CH, Kim KM, Zhang J. Tc-99m MIBI brain SPECT in the diagnosis of recurrent gliomas. Clin Nucl Med 1994; 19: 57-58.
22. Soler C, Perrot JL, Tiffet O, et al. The role of technetium-99m sestamibi single photon emission tomography in the follow-up of malignant melanoma and the detection of lymph node metastases. Eur J Nucl Med 1997; 24: 1522-1525.
23. Maffioli L, Gasparini M, Chili A, et al. Clinical role of technetium-99m sestamibi single-photon emission computerized tomography in evaluating pretreated patients with brain tumors. Eur J Nucl Med 1996; 23: 308-311.
24. O'Tuama LA, Treves S, Packard A, et al. Thallium-201 versus technetium-99m MIBI SPECT in evaluation of childhood brain tumors. J Nucl Med 1993; 34: 1045-1051.
25. O'Tuama L, Packard A, Treves S. SPECT imaging of pediatric brain tumors with hexakis (2-methoxyisobutylisonitrile) technetium-99m. J Nucl Med 1990; 31: 2040-2041.
26. 99mTc-sestamibi. Eur J Nucl Med 1998; 25: 401-409.
27. Andrews DW, Das R, Kim S, et al. Technetium-MIBI glioma imaging agent for the assessment of multi-drug resistance. Neurosurgery 1997; 40: 1323-1334.
28. Kostakoglu L, Kirath P, Ruacan S, et al. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. J Nucl Med 1998; 39: 228-233.
29. Buvat I, Bartlett ML, Kitsiou AN et al. A "hybrid" method for measuring myocardial wall thickening from gated PET/SPECT images. J Nucl Med 1997; 38: 324-329.
30. Galt JR, Garcia EV, Robbins WL, et al. Effects of myocardial wall thickness on SPECT quantification. IEEE Trans Med Imaging 1990; 9: 144-150.
31. Delmon-Moingeon LI, Piwnica-Worms D, Van Den Abbeele AD, et al. Uptake of the cation hexakis (2-methoxyisobutylisonitrile) technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50: 2198-2202.
32. Piwnica-Worms D, Kronauge JF, Chiu ML. Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells. J Nucl Med 1991; 32: 1992-1999.
33. Chiu ML, Kronauge JF, Piwnica-Worms D. Effects of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium-99m in cultured mouse fibroblasts. J Nucl Med 1993; 34: 1949-1952.
34. Duran Cordobes M, Starzec A, Delmon-Moingeon L, et al. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with gene expression. J Nucl Med 1996; 37: 1784-1789.
35. Andrews DW, Das R, Kim S, et al. Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance. Neurosurgery 1997; 40: 1323-1334.
36. Moretti JL, Azaloux H, Boisseron D, et al. Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression. Eur J Nucl Med 1996; 23: 980-986.